Video Experimental Relacionado
Updated: Feb 26, 2026

Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
Published on: January 1, 2017
Ácido zoledrónico para la osteoporosis asociada a la enfermedad renal crónica
Sukanya Sakthivel1, Krista Dybtved Kjærgaard1, Per Ivarsen1,2
1Department of Renal Medicine, Aarhus University Hospital, Aarhus, Denmark.
El zoledronato, un bisfosfonato, mostró ser prometedor en el tratamiento de la osteoporosis severa en un paciente en hemodiálisis a largo plazo. Se necesitan más ensayos para confirmar la seguridad y eficacia de los bisfosfonatos en pacientes con enfermedad renal crónica.
Videos de Conceptos Relacionados
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Chronic Kidney Disease III: Interprofessional Care
